Manual of clinical microbiology, Volume 2Includes information on infection detection and prevention and control, diagnostic technologies, bacteriology, antibacterial, antiviral, antifungal, and antiparasitic agents and susceptibility test methods, virology, mycology, and parasitology. |
Dall'interno del libro
Risultati 1-3 di 82
Pagina 1614
Nucleoside Reverse Transcriptase Inhibitors Antiretroviral drugs labeled NRTIs
were the first class of drugs approved for the treatment of HIV-1. RT is essential
for conversion of viral RNA into double-stranded DNA, which is integrated into ...
Nucleoside Reverse Transcriptase Inhibitors Antiretroviral drugs labeled NRTIs
were the first class of drugs approved for the treatment of HIV-1. RT is essential
for conversion of viral RNA into double-stranded DNA, which is integrated into ...
Pagina 1627
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 Sixteen antiretroviral drugs have
been approved for the treatment of HIV-1 infection: six nucleoside inhibitors and
one nucleotide RT inhibitor (NRTls), six protease inhibitors (Pis), and three ...
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 Sixteen antiretroviral drugs have
been approved for the treatment of HIV-1 infection: six nucleoside inhibitors and
one nucleotide RT inhibitor (NRTls), six protease inhibitors (Pis), and three ...
Pagina 1632
NA inhibitor resistance may be caused by mutations in HA or NA. Drug-resistant
HA mutations arise within or close to the receptor binding pocket and decrease
the affinity of HA for its cellular receptor ( 5 1 , 89, 90, 1 23 ). HA mutations allow ...
NA inhibitor resistance may be caused by mutations in HA or NA. Drug-resistant
HA mutations arise within or close to the receptor binding pocket and decrease
the affinity of HA for its cellular receptor ( 5 1 , 89, 90, 1 23 ). HA mutations allow ...
Cosa dicono le persone - Scrivi una recensione
Nessuna recensione trovata nei soliti posti.
Sommario
Actinobacillus Capnocytophaga MAY C CHU AND ROBBIN S WEYANT | xiii |
Fastidious | xix |
Rickettsia I 1005 | 1214 |
Copyright | |
39 sezioni non visualizzate
Altre edizioni - Visualizza tutto
Manual of clinical microbiology, Volume 1 American Society for Microbiology Visualizzazione frammento - 2003 |
Manual of Clinical Microbiology, Volume 1 Patrick R. Murray,Ellen Jo Baron,James H. Jorgensen Anteprima non disponibile - 2003 |
Parole e frasi comuni
acute acyclovir adenovirus agents amplification antigen antiviral assay blood capsid cell culture cell lines chronic Clin clinical specimens cytomegalovirus detection diagnosis dilution disease drug ELISA enteroviruses enzyme evaluation fluid ganciclovir gene genome genotype hepatitis C virus herpes simplex virus herpesvirus HIV infection human immunodeficiency virus human papillomavirus hybridization identification immune immunoassay immunofluorescence incubation influenza inhibitors inoculated laboratory lesions measles medium methods Microbiol Microbiology molecular monoclonal antibodies mumps mutations nucleic acid parvovirus B19 patients pediatric plasma polymerase chain reaction primary primers probes protein rabies reactive reagents replication resistance respiratory syncytial rhinovirus RT-PCR rubella samples sensitivity sequence sera serologic serotypes serum specific staining studies subtypes susceptibility swab therapy tion tissue titers transmission transplant vaccine viral RNA virion Virol Virology virus infection virus isolation virus type viruses
Riferimenti a questo libro
Informazioni bibliografiche
| Titolo | Manual of clinical microbiology, Volume 2 Manual of Clinical Microbiology, Ellen Jo Baron, ISBN 1555812554, 9781555812553 |
| Autori | Patrick R. Murray, Ellen Jo Baron, American Society for Microbiology |
| Edizione | 8 |
| Editore | ASM Press, 2003 |
| Provenienza dell'originale | la University of Michigan |
| Digitalizzato | 30 lug 2008 |
| ISBN | 1555812554, 9781555812553 |
| Lunghezza | 2113 pagine |
| Esporta citazione | BiBTeX EndNote RefMan |